BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12820722)

  • 1. Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.
    Julien S; Krzewinski-Recchi MA; Harduin-Lepers A; Gouyer V; Huet G; Le Bourhis X; Delannoy P
    Glycoconj J; 2001; 18(11-12):883-93. PubMed ID: 12820722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration.
    Julien S; Lagadec C; Krzewinski-Recchi MA; Courtand G; Le Bourhis X; Delannoy P
    Breast Cancer Res Treat; 2005 Mar; 90(1):77-84. PubMed ID: 15770530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
    Julien S; Adriaenssens E; Ottenberg K; Furlan A; Courtand G; Vercoutter-Edouart AS; Hanisch FG; Delannoy P; Le Bourhis X
    Glycobiology; 2006 Jan; 16(1):54-64. PubMed ID: 16135558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens.
    Ikehara Y; Kojima N; Kurosawa N; Kudo T; Kono M; Nishihara S; Issiki S; Morozumi K; Itzkowitz S; Tsuda T; Nishimura SI; Tsuji S; Narimatsu H
    Glycobiology; 1999 Nov; 9(11):1213-24. PubMed ID: 10536037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
    Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
    J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
    Marcos NT; Pinho S; Grandela C; Cruz A; Samyn-Petit B; Harduin-Lepers A; Almeida R; Silva F; Morais V; Costa J; Kihlberg J; Clausen H; Reis CA
    Cancer Res; 2004 Oct; 64(19):7050-7. PubMed ID: 15466199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer cells expressing cancer-associated sialyl-Tn antigen have less capacity to develop osteolytic lesions in a mouse model of skeletal colonization.
    Fujita R; Hamano H; Kameda Y; Arai R; Shimizu T; Ota M; Sato D; Kobayashi H; Iwasaki N; Takahata M
    Clin Exp Metastasis; 2019 Dec; 36(6):539-549. PubMed ID: 31595388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
    Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
    Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
    Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
    Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
    Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
    Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
    Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
    HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer.
    Sotiropoulou G; Kono M; Anisowicz A; Stenman G; Tsuji S; Sager R
    Mol Med; 2002 Jan; 8(1):42-55. PubMed ID: 11984005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines.
    Marcos NT; Cruz A; Silva F; Almeida R; David L; Mandel U; Clausen H; Von Mensdorff-Pouilly S; Reis CA
    J Histochem Cytochem; 2003 Jun; 51(6):761-71. PubMed ID: 12754287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation analysis between tumor-associated antigen sialyl-Tn expression and ST6GalNAc I activity in human colon adenocarcinoma.
    Vázquez-Martín C; Cuevas E; Gil-Martín E; Fernández-Briera A
    Oncology; 2004; 67(2):159-65. PubMed ID: 15539921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV.
    Harduin-Lepers A; Stokes DC; Steelant WF; Samyn-Petit B; Krzewinski-Recchi MA; Vallejo-Ruiz V; Zanetta JP; Augé C; Delannoy P
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):37-48. PubMed ID: 11062056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of sialyl-Tn epitopes on beta1 integrin alters epithelial cell phenotype, proliferation and haptotaxis.
    Clément M; Rocher J; Loirand G; Le Pendu J
    J Cell Sci; 2004 Oct; 117(Pt 21):5059-69. PubMed ID: 15383613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of a developmentally regulated N-acetylgalactosamine alpha2,6-sialyltransferase specific for sialylated glycoconjugates.
    Sjoberg ER; Kitagawa H; Glushka J; van Halbeek H; Paulson JC
    J Biol Chem; 1996 Mar; 271(13):7450-9. PubMed ID: 8631773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefined substrate specificity of ST6GalNAc II: a second candidate sialyl-Tn synthase.
    Kono M; Tsuda T; Ogata S; Takashima S; Liu H; Hamamoto T; Itzkowitz SH; Nishimura S; Tsuji S
    Biochem Biophys Res Commun; 2000 May; 272(1):94-7. PubMed ID: 10872809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers.
    Miyazaki K; Ohmori K; Izawa M; Koike T; Kumamoto K; Furukawa K; Ando T; Kiso M; Yamaji T; Hashimoto Y; Suzuki A; Yoshida A; Takeuchi M; Kannagi R
    Cancer Res; 2004 Jul; 64(13):4498-505. PubMed ID: 15231659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.
    Tamura F; Sato Y; Hirakawa M; Yoshida M; Ono M; Osuga T; Okagawa Y; Uemura N; Arihara Y; Murase K; Kawano Y; Iyama S; Takada K; Hayashi T; Sato T; Miyanishi K; Kobune M; Takimoto R; Kato J
    Gastric Cancer; 2016 Jan; 19(1):85-97. PubMed ID: 25532910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.